slides · global inventory
Solution
Slide type collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,880
Current window 5,131-5,160
Pages 296
Rows per page 30
Slide type
5,131-5,160 of 8,880
41
The slide highlights the lack of FDA-approved monthly IVR options for combined hormone therapy.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
43
The slide highlights the clinical need for a long-acting progesterone delivery system for preterm birth prevention and IVF support.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
44
The slide highlights the regulatory pathway (505(b)(2)) and the specific patient population (HR+ breast cancer survivors).Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
49
The slide uses a callout box to highlight the mechanism of action and clinical potential of GML.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
05
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
15
The slide uses a visual metaphor of a dendritic cell connecting to a stacked list of therapeutic outcomes.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
The slide uses a process flow framework to explain the production of an off-the-shelf cell therapy.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
Enochian Biosciences | Investor Presentation Deck | 39 slidesEnochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
22
The slide uses a process flow diagram to explain the therapeutic mechanism.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
25
The slide uses a list of key value propositions for the therapy.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
29
Mentions a specific cost range ($300k-$450k) as a pain point for current CAR-T therapies.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
31
Uses a vertical process-style list with icons to denote key product attributes.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
32
The diagram uses a visual contrast between infected and uninfected cells to demonstrate specificity.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
13
The slide highlights the user-experience features of the FF 91 vehicle.Faraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
14
Faraday Future | Investor Presentation Deck | 39 slidesFaraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations Beat · SolutionLoop · Quick Win Big Bet1 hit
30
The slide uses a modular product architecture to demonstrate manufacturing efficiency and scalability.Faraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations 1 hit
31
Includes technical specs like 185 Wh/kg, 98% efficiency, 142 kWh capacity, and 3.8 kW/kg ratio.Faraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations 1 hit
32
The slide uses a modular layout to detail specific technical capabilities of the vehicle.Faraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations 1 hit
34
The slide uses a hub-and-spoke diagram centered on 'FF Charging' to connect various charging solutions.Faraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations 1 hit
04
The slide uses a side-by-side comparison framework to highlight two major therapeutic areas.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
09
The slide uses a hub-and-spoke diagram to illustrate the three core pillars of the platform.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
10
The slide uses a process flow diagram to explain the therapeutic mechanism of action.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · Solution1 hit
04
Uses a two-column comparison layout to highlight clinical focus areas.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Loop · Aha Moment1 hit
09
The slide uses a hub-and-spoke diagram to illustrate the three core pillars of the platform.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
10
The slide uses a process flow diagram to explain the mechanism of action for the REQORSATM immunogene therapy.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
12
The slide uses a visual process flow to explain the mechanism of action for a biotech product.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
19
The slide uses bioluminescence imaging and bar charts to show immune cell population changes (T cells, NK cells, MDSC, DC).Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
23
Includes a histological image showing negative TUSC2 expression.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
30
Includes a diagram illustrating the biological process of alpha-to-beta cell reprogramming.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
34
Includes a microscopic image of cells.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit